ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,157Medicare Part D Prescriptions Filled, Including Refills

Rank: 281 out of 1454

$679K Total Retail Price of All Prescriptions

Rank: 246 out of 1454

728 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
21% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 728 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

7% of this provider’s 728 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 9,534 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

15 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 598 487 1 1
LISINOPRIL 373 325 2 4
AMLODIPINE BESYLATE 354 343 3 2
LEVOTHYROXINE SODIUM 350 312 4 5
OMEPRAZOLE 278 230 5 3
ZOLPIDEM TARTRATE 271 230 6 19
METOPROLOL TARTRATE 240 219 7 10
CITALOPRAM HBR 223 191 8 21
PANTOPRAZOLE SODIUM 222 202 9 31
FUROSEMIDE 217 172 10 6
METFORMIN HCL 214 174 11 8
METOPROLOL SUCCINATE 210 181 12 13
WARFARIN SODIUM 183 179 13 17
ATORVASTATIN CALCIUM 177 173 14 11
HYDROCHLOROTHIAZIDE 170 158 15 9
TRAMADOL HCL 166 126 16 20
SYNTHROID 144 134 17 25
NEXIUM 139 78 18 23
HYDROCODONE-ACETAMINOPHEN 133 91 S3 19 7
TRIAMTERENE-HCTZ 130 121 20 44
DIOVAN 129 102 21 40
POTASSIUM CHLORIDE 118 94 22 15
LISINOPRIL-HYDROCHLOROTHIAZIDE 110 98 23 27
GABAPENTIN 108 85 24 16
TAMSULOSIN HCL 103 103 25 34
GLIPIZIDE 101 83 26 62
LOSARTAN POTASSIUM 99 97 27 14
CRESTOR 97 85 28 22
SERTRALINE HCL 95 67 29 26
PREMARIN 90 90 R 30 131
PRAVASTATIN SODIUM 88 83 31 12
DOXAZOSIN MESYLATE 87 75 32 87
CYCLOBENZAPRINE HCL 87 55 R 32 59
ATENOLOL 81 70 34 18
AZITHROMYCIN 80 63 35 42
LEVOXYL 79 68 36 84
CLOPIDOGREL 79 66 36 32
ALENDRONATE SODIUM 68 64 38 35
FENOFIBRATE 67 57 39 68
TRAZODONE HCL 67 52 39 50
PROPRANOLOL HCL 66 62 41 129
CARVEDILOL 61 52 42 24
ADVAIR DISKUS 59 56 43 47
CYMBALTA 58 37 44 55
CIPROFLOXACIN HCL 56 48 45 64
BENAZEPRIL HCL 56 54 45 57
LOVASTATIN 53 50 47 39
ESCITALOPRAM OXALATE 51 51 48 78
FLUTICASONE PROPIONATE 51 32 48 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 15, 2009.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.